Complicated Urinary Tract Infection – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Symptomatic urinary infection, or a complicated urinary tract infection (UTI), can affect the bladder or kidneys and primarily afflicts individuals with structural or functional abnormalities in their genitourinary tract. Most UTIs arise from colonizing the urogenital area by bacteria typically found in the rectal and perineal regions. The usual culprits include Escherichia coli, Enterococcus, Klebsiella, Pseudomonas, and various Enterococcus or Staphylococcus species, with Escherichia coli being the most prevalent, followed by Klebsiella. Candida colonization is also possible in residential care patients, diabetics, those with indwelling catheters, or individuals with compromised immune systems. Escherichia coli and occasionally Klebsiella primarily cause simple UTIs. The pathophysiology of complicated UTIs can be categorized into four aspects:

 

1.       Structural abnormalities include calculi, infected cysts, renal or bladder abscesses, specific forms of pyelonephritis, spinal cord injuries (SCI), and catheter usage.

2.       Metabolic or hormonal irregularities, such as diabetes and pregnancy.

3.       Impaired host responses, notably in transplant recipients (particularly renal transplants) and AIDS patients.

4.       Unusual pathogens, including yeast.

To determine the eradication of complicated UTIs, the FDA recommends utilizing dual primary endpoints: a clinical response (resolution of symptoms with no new UTI symptoms) and a microbiological response (urine culture) showing less than 1,000 CFU/ml. Inadequate treatment of complicated UTIs raises the risk of early recurrence, therapy failure, and potential complications such as organ spread, abscess formation, or sepsis. Differential diagnosis includes conditions like abscesses, acute pyelonephritis, bladder cancer, chlamydial and genitourinary infections, cystitis, focal nephronia, herpes simplex, interstitial cystitis, obstructive pyelonephritis, pelvic inflammatory disease, prostatitis, sexually transmitted infections, urethritis, urolithiasis, and vaginitis.

 

·       The prevalence of bacteriuria is very high, reaching 100% in patients with chronic indwelling catheters, 30% to 40% in patients with a neurogenic bladder managed by intermittent catheterization, and 50% in elderly nursing home residents.

 

Thelansis’s “Complicated Urinary Tract Infection Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Complicated Urinary Tract Infection treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Complicated Urinary Tract Infection across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Complicated Urinary Tract Infection Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Complicated Urinary Tract Infection – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Complicated Urinary Tract Infection, Complicated Urinary Tract Infection market outlook, Complicated Urinary Tract Infection competitive landscape, Complicated Urinary Tract Infection market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)